Product Categories
| Country: | China |
|---|---|
| Tel: | +86 (311) 8781-9687 / +86 15081164951 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| N-[(1R,3r,5S)-9-azabicyclo[3.3.1]non-3-yl]-1-Methyl-1H-indazole-3-carboxaMide hydrochloride | C17H23ClN4O | 141136-01-8 | Details |
| SalMeterol Xinafoate Adduct IMpurity | C36H43NO6 | 1330076-52-2 | Details |
| Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) | C20H17NO3 | 72901-16-7 | Details |
| Glipizide IMpurity H | C15H23N3O3S | 10080-05-4 | Details |
| 5-BroMo-Nα-cyclohexyl-Nα-Methyltoluene-α,2-diaMine Dihydrochloride | C14H21BrN2 | 10076-98-9 | Details |
| 3,4-Dihydro-7-(4-hydroxybutoxy)-2(1H)-quinolinone | C13H17NO3 | 889443-20-3 | Details |
| N-(Methylsulfonyl)-4'-nitro-2'-phenoxyMethanesulfonanilide | C14H14N2O7S2 | 51765-72-1 | Details |
| Eprosartan related coMpound C | C8H8O4S | 4475-24-5 | Details |
| 1-[(2S)-3-BroMo-2-Methyl-1-oxopropyl]-L-proline | C9H14BrNO3 | 80629-35-2 | Details |
| BENAZEPRIL RELATED COMPOUND G (15 MG) ((3-(1 -ETHOXYCARBONYL-3-PHENYL-(1 S)-PROPYL)AMINO-2,3,4,5-TETRAHYDRO-2-OXO-1H-1-(3S)-BENZAZE-PINE)-1-ACETIC ACID, ETHYL ESTER) | C26H32N2O5 | 103129-58-4 | Details |
| Cimetidine Amide Dihydrochloride | C10H17N6OS | 52568-80-6 | Details |
| Loperamide | C29H33ClN2O3 | 106900-12-3 | Details |
| 4-diazoimidazole-5-carboxamide | C4H4N5O | 24316-91-4 | Details |
| citreoviridin | C23H30O6 | 25425-12-1 | Details |
| Ketotifen N-Oxide | C19H19NO2S | 88456-70-6 | Details |
| rac Ketoprofen AMide | C16H15NO2 | 59512-16-2 | Details |
| Bisacodyl Related Compound B (20 mg) (2,4'-(Pyridin-2-ylmethylene)diphenol) | C18H15NO2 | 16985-05-0 | Details |
| Duloxetine Related Compound F (10 mg) ((S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride) | C18H20ClNOS | 1104890-90-5 | Details |
| Des-Chloro Meclizine | C25H28N2 | 16896-82-5 | Details |
| (3RS)-N-Methyl-3-phenyl-3-[2-(trifluoroMethyl)-phenoxy]propan-1-aMine Hydrochloride(2-TrifluoroMethylisoMer of Fluoxetine Hydro-chloride) | C18H18F3NO2 | 199188-97-1 | Details |
| 6,6'-DiMethoxy-2,2'-binaphthalene | C22H18O2 | 29619-45-2 | Details |
| N-Deethyl DorzolaMide Hydrochloride | C8H13ClN2O4S3 | 164455-27-0 | Details |
| Ethyl2,3-dihydro-3-oxo-1,2-benzisothiazole-2-acetate-1,1-dioxide | C11H11NO5S | 24683-20-3 | Details |
| Ondansetron Impurity B | C37H38N6O2 | 1076198-52-1 | Details |
| 4-Nitro-2-phenoxyaniline | C12H10N2O3 | 5422-92-4 | Details |
| N-Carbamoyl Carbamazepine | C16H13N3O2 | 1219170-51-0 | Details |
| 3-Dechloro-4-chloro Lamotrigine | C9H7Cl2N5 | 38943-76-9 | Details |
| [3-[[[2-(DiaMinoMethyleneaMino)-4-thiazolyl]Methyl]thio]propionyl]sulfaMide Hydrochloride (FaMotidine IMpurity) | C8H15ClN6O3S3 | 76824-17-4 | Details |
| 4-Deschloro-4-(2-furanylMethyl)aMino FuroseMide | C17H17N3O6S | 5046-19-5 | Details |
| Moexipril Diketopiperazine | C27H32N2O6 | 103733-51-3 | Details |
| Famciclovir Related Compound A (20 mg) (2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol hydrochloride) | C10H16ClN5O2 | 246021-75-0 | Details |
| GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT) | C14H22GdN4O6 | 112188-16-6 | Details |
| NIMODIPINE RELATED COMPOUND A (50 MG) (2-METHOXYETHYL 1-METHYLETHYL 2,6-DIMETHYL-4-(3-NITROPHENYL)PYRIDINE-3,5-DICARBOXYLATE) | C21H24N2O7 | 85677-93-6 | Details |
| METFORMIN RELATED COMPOUND B (25 MG) (1-METHYLBIGUANIDE HYDROCHLORIDE) | C3H10ClN5 | 1674-62-0 | Details |
| N-[2-[[[2-[(Dimethylamino)methyl]-4-thiazolyl]methyl]sulfinyl]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine | C12H21N5O3S2 | 102273-13-2 | Details |
| Oxaliplatin impurity D | C8H12N2O4Pt | 61758-77-8 | Details |
| GADOTERIDOL RELATED COMPOUND C (50 MG) (1,4,7,10-TETRAAZA-11-OXO-BICYCLO[8.2.2]TETRADE-CANE-4,7-DIACETIC ACID) | C14H24N4O5 | 220182-19-4 | Details |
| GLYBURIDE RELATED COMPOUND B (25 MG) (METHYL-[[4-[2-[(5-CHLORO-2-METHOXYBENZOYL)-AMINO]ETHYL]PHENYL]SULFONYL]CARBAMATE) (AS) | C18H19ClN2O6S | 21165-77-5 | Details |
| 3-(1-HYDROXYETHYL)BENZOPHENONE | C15H14O2 | 67173-18-6 | Details |
| Trimipramine N-Oxide | C20H26N2O | 14171-70-1 | Details |
| 4-phenylbutylphosphonic acid | C10H15O3P | 46348-61-2 | Details |
| [1-hydroxy-2-(2-pyridinyl)ethylidene]bis(phosphonic acid) | C7H11NO7P2 | 105462-23-5 | Details |
| VERAPAMIL RELATED COMPOUND D (50 MG) (5,5'-[[2-(3,4)DIMETHOXYPHENYL)ETHYL]IMINO]BIS[2-(3,4-DIMETHOXYPHENYL)-2-(1-METHYLETHYL)PENTANENI-TRILE] HYDROCHLORIDE) | C42H58ClN3O6 | 190850-50-1 | Details |
| METHYL RICINOLEATE | C19H36O3 | 41989-07-5 | Details |
| Hydroxyzine Acetic Acid Dihydrochloride | C23H29ClN2O4 | 83881-56-5 | Details |
| Meta-GliMepiride IMpurity | C24H34N4O5S | 791104-62-6 | Details |
| NabuMetone DiMer IMpurity | C27H26O3 | 343272-53-7 | Details |
| (5RS)-5-(4-Methoxyphenyl)-3-Methyl-1-oxa-3-azaspiro-[5.5]undecane Hydrochloride | C17H26ClNO2 | 93413-56-0 | Details |
| 1-[(2,4,6-TriMethoxyphenyl)Methyl]piperazine Hydrochloride | C14H23ClN2O3 | 113698-83-2 | Details |
| Ganciclovir Dipropionate | C15H21N5O6 | 86357-20-2 | Details |
| 1,3-Bis[(1-Methylethyl)aMino]-2-propanol Dihydrochloride | C9H23ClN2O | 73313-36-7 | Details |
| LARD OIL | 8016-28-2 | Details |
| TIZANIDINE RELATED COMPOUND B (50 MG) (N-ACETYLTIZANIDINE) | C11H10ClN5OS | 173532-15-5 | Details |
| PREDNICARBATE RELATED COMPOUND A (20 MG) (1,2-DIHYDROPREDNICARBATE) | C27H38O8 | 671225-26-6 | Details |
| 10-methoxy-4-(1-methylpiperidin-4-yl)-4H-benzo[4.5]cyclohepta[1,2-b]thiophene-4-ol | C20H23NO2S | 59743-88-3 | Details |
| 17-deacetylvecuronium | C32H55BrN2O3 | 50587-95-6 | Details |
| Dehydrodeoxy Donepezil (Donepezil Impurity) | C24H29NO2 | 120013-45-8 | Details |
| 3-[4-(2-Methoxyethyl)phenoxy]- | C12H18O4 | 62572-90-1 | Details |
| N-Deshydroxy Ciclopirox | C12H17NO | 67587-24-0 | Details |
| 5-DesMethyl-6-Methyl Glipizide | C21H27N5O4S | 66375-96-0 | Details |
| N-Denitroso-N'-nitroso LoMustine | C9H16ClN3O2 | 54749-91-6 | Details |
| Moexipril tert-Butyl Ester Maleic Acid Salt | C35H46N2O11 | 103733-40-0 | Details |
| 4-Desisopropyl-4-ethyl Nateglinide | C18H25NO3 | 105746-45-0 | Details |
| Prednicarbate Related Compound C (20 mg) (prednisolone-21-propionate) | C24H32O6 | 5740-62-5 | Details |
| 2-[[(3,5-DiMethyl-2-pyridinyl)Methyl]thio]-6-Methoxy-1H-benziMidazole | C16H17N3OS | 704910-89-4 | Details |
| N-[4-[β-(5-Methylpyrazine-2-carboxaMido)ethyl]phenylsulfonyl]Methylurethane | C16H18N4O5S | 33288-74-3 | Details |
| rac-cis-3-Dechloro Sertraline Hydrochloride | C17H19Cl2N | 79559-98-1 | Details |
| BenzenesulfonaMide, N,N'-[1,2-ethanediylbis[oxy[5-(2-Methoxyphenoxy)[2,2'-bipyriMidine]-6,4-diyl]]]bis[4-(1,1-diMethylethyl)- | C52H52N10O10S2 | 1097263-60-9 | Details |
| 8-Desethyl Etodolac | C15H17NO3 | 41339-67-7 | Details |
| N-ethyl-p-methoxy-alpha-methylphenethylamine hydrochloride | C12H20ClNO | 93963-24-7 | Details |
| Isopropyl 4-Hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide (Piroxicam Impurity I) | C12H13NO5S | 76508-35-5 | Details |
| Platinum, (1,2-cyclohexanediamine-N,N')dinitrato-,(sp-4-2, 1R-trans)- | C6H12N4O6Pt | 66900-68-3 | Details |
| 3-[2-(Diaminomethyleneamino)-1,3-thiazol-4-ylmethylsulphinyl]-N-sulphamoylpropanamidine | C8H15N7O3S3 | 90237-03-9 | Details |
| Propyl Itraconazole | C34H36Cl2N8O4 | 74855-91-7 | Details |
| Ethyl-2-(6-aMino-2,3-dichlorobenzylaMino)acetate Hydrochloride | C11H15Cl3N2O2 | 85325-12-8 | Details |
| Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) | C22H19NO4 | 111664-35-8 | Details |
| Trospium Chloride Related Compound C | C16H15ClO2 | 3464-71-9 | Details |
| N-(Methylsulfonyl)-N-(2-phenoxyphenyl)MethanesulfonaMide | C14H15NO5S2 | 905858-63-1 | Details |
| 6-O-Benzyl-4-dehydroxy-4-diMethylphenylsilyl Entecavir | C27H31N5O2Si | 649761-24-0 | Details |
| Des(N'-Methyl-2-nitro-1,1-ethenediaMino) N'-Methylureido Nizatidine | C11H20N4OS2 | 82586-81-0 | Details |
| BenzenesulfonaMide, N-[1,6-dihydro-5-(2-Methoxyphenoxy)-6-oxo[2,2'-bipyriMidin]-4-yl]-4-(1,1-diMethylethyl)- | C25H25N5O5S | 174227-14-6 | Details |
| 1-(4-Ethenylphenoxy)-3-[(1-Methylethyl)aMino]-2-propanole | C14H21NO2 | 933468-54-3 | Details |
| BIRG 613 BS | C15H16N4O | 287980-85-2 | Details |
| CLADRIBINE RELATED COMPOUND A (20 MG) (2-METHOXY-2'-DEOXYADENOSINE) | C11H15N5O4 | 24757-70-8 | Details |
| 5-Carboxy-2'-deoxyuridine | C10H12N2O7 | 14599-46-3 | Details |
| 4-Desmethoxy-4-chloro Omeprazole Sulfide | C16H16ClN3OS | 220757-74-4 | Details |
| CARBAMICACID,METHYL[(4-METHYLPHEN | C10H13NO4S | 32258-50-7 | Details |
| Dantrolene Related Compound B (50 mg) (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone) | C14H12N4O6 | 57268-33-4 | Details |
| Doxazosin Related Compound F (15 mg) (N,N'-bis(1,4-benzodioxane-2-carbonyl)piperazine) | C22H22N2O6 | 617677-53-9 | Details |
| (R,S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate | C13H20N2O2 | 25081-93-0 | Details |
| Verapamil Related Compound A (50 mg) (3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride) | C17H27ClN2O2 | 67775-97-7 | Details |
| MetoclopraMide IMpurity F | C13H20ClN3O2 | 38339-95-6 | Details |
| 1-Isopropyl Etodolac | C18H23NO3 | 57917-63-2 | Details |
| TIZANIDINE RELATED COMPOUND C (50 MG) (1-ACETYLIMIDAZOLIDINE-2-THIONE) | C5H8N2OS | 5391-52-6 | Details |
| methyl 3-oxo1,2-benzisothiazole-2(3H)-acetate 1,1-dioxide | C10H9NO5S | 6639-62-9 | Details |
| METHYL MYRISTELAIDATE | C15H28O2 | 72025-18-4 | Details |
| Famotidine Related Compound A Hydrochloride | C8H15ClN6S2 | 76833-47-1 | Details |
| cis-Glimepiride | C24H34N4O5S | 684286-46-2 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 | ||||